Genesis Healthcare, Inc.
GENN · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Revenue | $4 | $5 | $5 | $5 |
| % Growth | -14.4% | -8.3% | -7.4% | – |
| Cost of Goods Sold | $2 | $2 | $3 | $3 |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 42.2% | 45.6% | 44% | 43.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $2 | $0 |
| Operating Income | $1 | $1 | $0 | $0 |
| % Margin | 27% | 32.6% | 4.2% | 3.4% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$0 | $0 | -$0 | -$1 |
| Tax Expense | -$0 | $0 | -$0 | -$0 |
| Net Income | -$0 | $0 | -$0 | -$1 |
| % Margin | -1.5% | 0.3% | -4.7% | -10.8% |
| EPS | -0.53 | 0.14 | -2.33 | -6.15 |
| % Growth | -478.6% | 106% | 62.1% | – |
| EPS Diluted | -0.53 | 0.1 | -2.33 | -6.15 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 3.5% | 6.9% | 6.2% | -4% |